Cleared Traditional

K761207 - HEMATRAK RBC MORPHOLOGY

K761207 is an FDA 510(k) clearance for HEMATRAK RBC MORPHOLOGY, manufactured by Geometric Data, Div. Smithkline Corp.. The device is a Class 2 Hematology device with product code GKZ cleared through the Traditional 510(k) pathway after a 315-day FDA review.

K761207 · Geometric Data, Div. Smithkline Corp. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1977
Decision
315d
Days
Class 2
Risk

K761207 is an FDA 510(k) clearance for the HEMATRAK RBC MORPHOLOGY. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Geometric Data, Div. Smithkline Corp. (Mchenry, US). The FDA issued a Cleared decision on October 18, 1977 after a review of 315 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Geometric Data, Div. Smithkline Corp. devices

FDA 510(k) Submission Details - K761207

510(k) Number K761207 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 07, 1976
Decision Date October 18, 1977
Days to Decision 315 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
202d slower than avg
Panel avg: 113d · This submission: 315d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 305
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K761207.
HEMATRAK MODEL 480
K790816 · Geometric Data, Div. Smithkline Corp. · Jul 1979
CONTEXT FILTER
K791108 · Geometric Data, Div. Smithkline Corp. · Jul 1979
PLATELETS/CU MM
K780577 · Geometric Data, Div. Smithkline Corp. · May 1978
AUTO DIFFERENTIAL CELL COUNTER SYSTEM
K770244 · Abbott Laboratories · Aug 1977
HEMATRAK
K770680 · Geometric Data, Div. Smithkline Corp. · Jul 1977
ATYPIA PROFILE MONITOR
K770550 · Geometric Data, Div. Smithkline Corp. · Jun 1977